Von Recklinghausen disease and gastrointestinal stromal tumors

American Journal of Surgery

Volumn 185, Issue 1, 2003, Pages 86-87

  Giuly, Jules A ^a   Picand, Robert ^a   Giuly, Didier ^a   Monges, Bruno ^a   Nguyen Cat, Roger ^a  

^a Clinique Fallen   (France)

Author keywords

Digestive localizations of Recklinghausen disease; Gastrointestinal stromal tumors; Stromal tumors; Von Recklinghausen disease

Indexed keywords

ENZYME INHIBITOR; PHOSPHOTRANSFERASE; STI 51; TYROSIUM KINASE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE REPORT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG MECHANISM; FEMALE; GASTROINTESTINAL STROMAL TUMOR; HUMAN; IMMUNOCHEMISTRY; MEDICAL LITERATURE; METASTASIS; NEUROFIBROMATOSIS; PRIORITY JOURNAL; SURGICAL TECHNIQUE; TUMOR RECURRENCE;

BIOPSY, NEEDLE; DIAGNOSIS, DIFFERENTIAL; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEOPLASM STAGING; NEUROFIBROMATOSIS 1; RISK ASSESSMENT; STROMAL CELLS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 0037225624     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(02)01111-X     Document Type: Article

References (6)

1. Miettinen M., Sarlomo-Rikala M., Lasota J. Gastrointestinal stromal tumors recent advances in understanding of their biology . Hum Pathol. 10:1999;1213-1219.
2. Fuller C.E., Williams G.T. Gastrointestinal manifestations of type I neurofibromatosis (von Recklinghausen disease). Histopathology. 19:1991;1-11.
3. Dewailly A., Yasdanparrah Y., Renou C., Paris J.C. Urgences abdominales et neurofibromatose de von Recklinghausen. Gastro-Enterol Clin Biol. 21:1997;227-228.
4. Joensuu H., Roberts R.J., Sarlomo-Rikala M., et al. Effect of the tyrosim-kinase inhibitor STI571 in a patient with a metastatic gastrointestinal tumor. N Engl J Med. 344:2001;1052-1056.
5. Blanke C.D., Von Meheken M., Joensuu H., et al. Evaluation of the safety and efficacy of an oral molecularly targeted therapy STI571 in patients with unresectable or metastatic gastro-intestinal stromal tumors expressing CKIT (CD117). [Abstract] Proc ASCO. 80:2001;1.
6. Van Oostream A.T., Judson I., Verweig J., et al. STI571, an active drug in metastatic gastrointestinal stromal tumors (GIST) an EORTC phase I study . Lancet. 358:2001;1421-1423.